How much do Back to Index and ICICI Prudential Pharma Healthcare and Diagnostics Fund overlap?

They share 10 common holdings, a weighted portfolio overlap of about 26.39% (moderate overlap — a meaningful shared core), as on May 2026. Information only, not investment advice.

What does 26.39% overlap mean?

Weighted overlap sums the smaller of the two weights for each shared stock, so it approximates how much of the two portfolios coincide. Higher overlap means holding both funds adds less diversification.

Fund overlap

Back to Index vs ICICI Prudential Pharma Healthcare and Diagnostics Fund

Motilal Oswal MF · Index FundICICI Pru MF · Sectoral / Thematic· as on May 2026

Weighted portfolio overlap

26.39%

Moderate overlap

Common

Only Back

Only ICICI

10 of 57 unique stocks in common · Jaccard: 17.5%

Common holdings

Stock	in Back	in ICICI
BioconPharmaceuticals & Biotechnology	4.54%	4.71%
Mankind PharmaPharmaceuticals & Biotechnology	4.49%	7.03%
Alkem LaboratoriesPharmaceuticals & Biotechnology	5.58%	4.08%
LupinPharmaceuticals & Biotechnology	9.88%	3.06%
Abbott IndiaPharmaceuticals & Biotechnology	2.32%	2.14%
JB Chemicals & PharmaceuticalsPharmaceuticals & Biotechnology	2.95%	1.94%
Aurobindo PharmaPharmaceuticals & Biotechnology	6.87%	1.92%
Syngene InternationalHealthcare Services	1.57%	2.99%
Cohance LifesciencesPharmaceuticals & Biotechnology	1.39%	4.37%
PfizerPharmaceuticals & Biotechnology	1.26%	1.98%

FAQ

How much do Back to Index and ICICI Prudential Pharma Healthcare and Diagnostics Fund overlap?: They share 10 common holdings, a weighted portfolio overlap of about 26.39% (moderate overlap — a meaningful shared core), as on May 2026. Information only, not investment advice.
What does 26.39% overlap mean?: Weighted overlap sums the smaller of the two weights for each shared stock, so it approximates how much of the two portfolios coincide. Higher overlap means holding both funds adds less diversification.

Related comparisons

Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.